Skip to main content
Penumbra Inc logo

Penumbra Inc — Investor Relations & Filings

Ticker · PEN ISIN · US70975L1070 LEI · 549300RGE06P3ECANU72 US Manufacturing
Open in API
Filings indexed 922 across all filing types
Latest filing 2017-08-03 Director's Dealing
Country US United States of America
Listing US PEN

About Penumbra Inc

https://www.penumbrainc.com/

Penumbra Inc. is a global healthcare company that designs, develops, manufactures, and markets innovative medical devices. The company specializes in interventional therapies for challenging medical conditions within the neurovascular and peripheral vascular markets. Its product portfolio addresses conditions such as acute ischemic stroke, hemorrhagic stroke, and vascular aneurysms. Key technologies include aspiration systems for the revascularization of patients with acute ischemic stroke (e.g., the PENUMBRA SYSTEM) and embolization coil systems for vessel occlusion (e.g., the Swift Coil System). The company focuses on creating novel technologies to improve patient outcomes.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2017-08-03 English
FORM 4/A
Director's Dealing
2017-07-25 English
FORM 4
Director's Dealing
2017-07-24 English
FORM 4
Director's Dealing
2017-07-20 English
ITEM 2.01 FORM 8-K
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The specific item reported is Item 2.01, which relates to the completion of an acquisition of assets. The document details the acquisition of Crossmed S.p.a. by Penumbra, Inc., including purchase price and terms. It also mentions that financial statements and pro forma financial information will be filed later as amendments. This type of filing is a current report announcing a material acquisition event, which fits the category of M&A Activity (TAR). The document is not a full merger proxy statement or tender offer filing (MA), but rather an 8-K announcement of an acquisition event, which aligns with M&A Activity (TAR). The document length is under 5,000 characters, but it contains substantive information about the acquisition, not just a report publication announcement. Therefore, the correct classification is M&A Activity (TAR) with high confidence.
2017-07-10 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content describes a voluntary field removal of certain product lots due to a raw material issue, which is an operational event rather than a financial report or management change. The document is short (2808 characters) and does not contain financial statements or detailed analysis. It is not an announcement of a report publication but a regulatory disclosure of an event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2017-06-13 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.